Industry Overview

North American capnography devices market was valued at $196.8 million in 2025 and is projected to reach $296.4 million by 2035, growing at a CAGR of 4.2% during the forecast period (2026–2035). The North America capnography devices market is expanding steadily as hospitals, emergency departments, and ambulatory surgery centers accelerate the integration of continuous respiratory monitoring into routine care pathways. Growth is being driven by the rising emphasis on real-time CO? measurement for improved clinical decision-making in anesthesia, procedural sedation, and critical care. Adoption is further reinforced by the increasing incidence of chronic respiratory disorders, growing surgical volumes, and stringent regional guidelines that mandate capnography use in high-risk settings. The market is also benefiting from rapid technological progress, particularly handheld and multiparameter systems equipped with advanced waveform analysis, automated alarm management, and enhanced connectivity for electronic medical record integration.

Market Dynamics

Strengthening Focus on Respiratory Monitoring and Patient Safety

The North American capnography devices market is expanding steadily as hospitals, ambulatory centers, and emergency medical services intensify efforts to improve respiratory monitoring standards. Rising prevalence of COPD, asthma, obstructive sleep apnea, and other chronic respiratory conditions is prompting broader use of capnography across clinical environments. Surgical volumes continue to grow across the United States and Canada, increasing the need for continuous EtCO? monitoring in anesthesia, procedural sedation, and post-operative care. Heightened emphasis by regulatory authorities, including the FDA and Health Canada, on patient-safety compliance and standardized monitoring protocols is further accelerating device adoption. As healthcare providers prioritize early detection of respiratory compromise, high-accuracy capnography systems are becoming essential tools in critical-care and emergency medicine workflows across North America.

Rapid Integration of Advanced Technologies and Connected Monitoring Platforms

Technological advancements remain key drivers of market growth in North America. Healthcare organizations are increasingly adopting portable, handheld, and multiparameter capnography devices to support flexible, real-time monitoring across intensive care, transport, and field-care settings. Integration of digital technologies such as waveform analytics, wireless connectivity, EMR interoperability, and cloud-supported data management is enhancing clinical decision-making and workflow efficiency. Manufacturers are introducing devices with improved sensor accuracy, faster response times, and user-friendly interfaces to meet the needs of high-acuity environments. Strong presence of leading medical device innovators, combined with ongoing investments in smart monitoring ecosystems, is accelerating the shift toward advanced capnography solutions. As a result, connected respiratory-monitoring platforms are becoming central to modern clinical practice throughout the United States and Canada.

Market Segmentation

• Based on the product type, the market is segmented into handheld, standalone, multiparameter, and others.
• Based on the application, the market is segmented into respiratory disease, cardiology, trauma & emergency, and others.
• Based on the end-user, the market is segmented into hospital & clinics and ambulatory surgical centers.

Handheld Segment to Lead the North America Market with the Largest Share

The handheld segment is expected to maintain its dominant position in the North America capnography devices market, driven by strong demand for portable, fast-response monitoring tools across clinical and pre-hospital settings. Emergency medical services, ambulatory care providers, and hospital-based rapid-response teams increasingly rely on handheld devices for real-time respiratory assessment during trauma care, patient transport, and procedural sedation. The segment’s leadership is further reinforced by continuous advancements in sensor precision, compact designs, wireless connectivity, and extended battery life. As North America places greater emphasis on point-of-care diagnostics and mobile monitoring, handheld capnography devices remain the preferred choice for clinicians seeking accuracy, convenience, and rapid deployment. This sustained adoption ensures the segment’s leading market share throughout the forecast period.

Hospitals & Clinics: Central to Market Expansion in North America

Hospitals and clinics represent the most influential end-user segment in the North America capnography devices market, driven by their critical role in surgical monitoring, anesthesia care, and management of respiratory compromise. Continuous EtCO? monitoring has become a standard requirement in operating rooms, ICUs, emergency departments, and procedural sedation units across the United States and Canada. Increasing surgical volumes, heightened incidence of chronic respiratory conditions, and strict regulatory emphasis on patient safety continue to boost device penetration. Moreover, accelerated integration of multiparameter monitoring platforms and connected health technologies is elevating workflow efficiency and clinical accuracy in hospital environments. As healthcare systems invest in advanced critical-care infrastructure and expand adoption of digital monitoring solutions, hospitals and clinics will remain pivotal contributors to overall market growth in North America.

Regional Outlook

North America capnography devices market is further divided by countries, including US and Canada.

US Dominates the Market with Major Share

The US maintains a commanding position in the drug discovery informatics market, supported by its mature pharmaceutical ecosystem and strong focus on data-driven R&D. Leading biopharma companies, academic research centers, and technology developers are continually investing in advanced computational platforms that enhance target identification, virtual screening, and predictive modeling. The country’s robust funding landscape, spanning federal research programs, venture capital, and private-sector innovation, enables rapid adoption of next-generation AI and cloud-based informatics tools. As US institutions prioritize faster development timelines and more accurate early-stage decision-making, demand for integrated informatics platforms continues to rise. These strengths collectively reinforce the US’s position as a central hub for innovation and leadership within the global drug discovery informatics market.

Market Players Outlook

The major companies operating in the North America capnography devices market include Becton, Dickinson and Company, GE HealthCare Technologies Inc., Koninklijke Philips N.V., Masimo Corporation, Medtronic plc, among others. Market players are leveraging partnerships, collaborations, mergers, and acquisition strategies for business expansion and innovative product development to maintain their market positioning.

Recent Development

• In May 2025, Masimo Corporation announced Q1 results highlighting the growth of its capnography business and emphasized the expansion of its NomoLine capnography line, reinforcing its commitment to advanced respiratory monitoring technologies.
• In April 2025, Nihon Kohden Corporation entered a strategic partnership with Philips Healthcare to co-develop and co-market integrated capnography-enabled monitors for ICUs and post-anesthesia care units, signaling growing interest in interoperable, multi-parameter patient monitoring solutions.

The Report Covers

• Market value data analysis of 2025 and forecast to 2035.
• Annualized market revenues ($ million) for each market segment.
• Country-wise analysis of major geographical regions.
• Key companies operating in the North America capnography devices Based on the availability of data, information related to new products and relevant news is also available in the report.
• Analysis of business strategies by identifying the key market segments positioned for strong growth in the future.
• Analysis of market-entry and market expansion strategies.
• Competitive strategies by identifying ‘who-stands-where’ in the market.